title: Predictors of benefit in colorectal cancer treated with cetuximab: are we getting "Lost in TranslationAL"?
authors.forename: Chiara
authors.initials: C
authors.lastname: Cremolini
authors.forename: Fotios
authors.initials: F
authors.lastname: Loupakis
authors.forename: Annamaria
authors.initials: A
authors.lastname: Ruzzo
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Perrone
authors.forename: Eliana
authors.initials: E
authors.lastname: Rulli
authors.forename: Bruno
authors.initials: B
authors.lastname: Vincenzi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Tonini
authors.forename: Francesco
authors.initials: F
authors.lastname: Graziano
authors.forename: Andrea Onetti
authors.initials: AO
authors.lastname: Muda
authors.forename: Alfredo
authors.initials: A
authors.lastname: Falcone
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D016283:Proto-Oncogene Proteins p21(ras); D011944:Receptors, Androgen / Q000378:metabolism; D012189:Retrospective Studies; D018631:ras Proteins / Q000235:genetics
chemical_list: C410798:AR protein, human; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D011944:Receptors, Androgen; D066246:ErbB Receptors; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins; D000068818:Cetuximab